Solventum Corporation (SOLV)
NYSE: SOLV · Real-Time Price · USD
74.13
+0.92 (1.26%)
At close: Sep 16, 2025, 4:00 PM EDT
74.13
0.00 (0.00%)
After-hours: Sep 16, 2025, 7:16 PM EDT
Solventum Revenue
Solventum had revenue of $2.16B in the quarter ending June 30, 2025, with 3.84% growth. This brings the company's revenue in the last twelve months to $8.39B, up 2.21% year-over-year. In the year 2024, Solventum had annual revenue of $8.25B with 0.70% growth.
Revenue (ttm)
$8.39B
Revenue Growth
+2.21%
P/S Ratio
1.54
Revenue / Employee
$381,273
Employees
22,000
Market Cap
12.85B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 8.25B | 57.00M | 0.70% |
Dec 31, 2023 | 8.20B | 67.00M | 0.82% |
Dec 31, 2022 | 8.13B | -41.00M | -0.50% |
Dec 31, 2021 | 8.17B | 890.00M | 12.22% |
Dec 31, 2020 | 7.28B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
SOLV News
- 7 days ago - Solventum Corporation (SOLV) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 8 days ago - Solventum Announces Pricing of its Upsized $2 Billion Note Tender Offers - PRNewsWire
- 8 days ago - Solventum Announces Early Tender Results and Upsizing of its Note Tender Offers - PRNewsWire
- 11 days ago - Solventum Corporation (SOLV) Presents At 2025 Wells Fargo Healthcare Conference (Transcript) - Seeking Alpha
- 14 days ago - Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. - PRNewsWire
- 14 days ago - Thermo Fisher Scientific Completes Acquisition of Solventum's Purification and Filtration Business - Business Wire
- 19 days ago - Solventum to Participate in Upcoming Investor Conferences - PRNewsWire
- 25 days ago - Solventum Announces $1.75 Billion Note Tender Offers - PRNewsWire